An imbalance in BAX (a pro-apoptotic protein) and BCL-2 (an anti-apoptotic protein) expression is known to be involved in hepatocyte apoptosis during NAFLD [18,43]. Here, BCL2 is linked to metabolic dysfunction-associated steatotic liver disease.